Osaic Holdings’s Kairos Pharma KAPA Stock Holding History

Osaic Holdings’s Portfolio KAPA Stock Details KAPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,045	Closed	-$9.26K	–	8115
2025 Q4	$9.26K	Buy	+13,045	New	+$12.2K	﹤0.01%	6388

Other funds holding KAPA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

SFG

SevenBridge Financial Group Harrisburg, Pennsylvania $640M AUM 27.29% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings's KAPA Position: Q1 2026 in Review

Osaic Holdings sold out of Kairos Pharma (KAPA) in Q1 2026, closing a stake of 13,045 shares — an estimated $9.26K sold.

Osaic Holdings first reported a position in KAPA in Q4 2025 and held it in 1 quarter. The position peaked at $9.26K in Q4 2025. 11 funds tracked by Wall St. Rank hold KAPA as of Q1 2026.

Osaic Holdings reported no remaining Kairos Pharma position as of Q1 2026 after selling out during the quarter.
Osaic Holdings sold 13,045 Kairos Pharma shares in Q1 2026, an estimated $9.26K.
Osaic Holdings first reported a position in Kairos Pharma in Q4 2025 and held it in 1 quarter.
Osaic Holdings's Kairos Pharma position peaked at $9.26K in Q4 2025.
11 funds tracked by Wall St. Rank held Kairos Pharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.